InvestorsHub Logo
Followers 3
Posts 793
Boards Moderated 0
Alias Born 02/07/2016

Re: None

Saturday, 11/04/2017 3:01:21 PM

Saturday, November 04, 2017 3:01:21 PM

Post# of 8484
Breakthrough designation by FDA!This safe harbor statement is still very intriguing to me.

“ and statements concerning future actions relating to the development of PEGPH20, including receipt by the FDA of breakthrough therapy designation) that involve risk and uncertainties that could cause actual results to differ materially from those in the forward-looking statements.”

https://www.prnewswire.com/news-releases/fda-advisory-committee-provides-unanimous-recommendation-for-subcutaneous-rituximab-coformulated-with-halozyme-enhanze-technology-300431221.html
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent HALO News